(Q37435926)

20 August 2017

1 reference

title

TB vaccines: current status and future perspectives (English)

1 reference

20 August 2017

Peter Andersen

4

0 references

author name string

Claus Aagaard

series ordinal

1

1 reference

PubMed ID

19350048

20 August 2017

Jes Dietrich

series ordinal

2

1 reference

PubMed ID

19350048

20 August 2017

Mark Doherty

series ordinal

3

1 reference

20 August 2017

7 April 2009

1 reference

Immunology & Cell Biology

20 August 2017

1 reference

20 August 2017

87

1 reference

20 August 2017

4

1 reference

20 August 2017

279-286

1 reference

Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction?

20 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Mycobacterial infections in Norway: a preliminary note on determining their identity and frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Studies on the treatment of experimental tuberculosis of the guinea pig with intermittent doses of isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Real world TB vaccines: clinical trials in TB-endemic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Tuberculosis vaccines - an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Tuberculosis vaccine development; from mouse to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

The contribution of immunology to the rational design of novel antibacterial vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Disseminated tuberculosis in interferon gamma gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Interferon-gamma and interleukin-12 pathway defects and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Identification of Mycobacterium tuberculosis vaccine candidates using human CD4+ T-cells expression cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Mycobacterial mutants with defective control of phagosomal acidification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Antituberculous immunity induced in mice by vaccination with killed tubercle bacilli or with a soluble bacillary extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

TB vaccines: progress and problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Immunology of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Mutants of Mycobacterium tuberculosis lacking three of the five rpf-like genes are defective for growth in vivo and for resuscitation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

The structure of a resuscitation-promoting factor domain from Mycobacterium tuberculosis shows homology to lysozymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Advances in tuberculosis vaccine strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Innate immunity of the newborn: basic mechanisms and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Pulmonary necrosis resulting from DNA vaccination against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Therapy of tuberculosis in mice by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

IC31 and IC30, novel types of vaccine adjuvant based on peptide delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Reactivation of latent tuberculosis infection in TNF-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Ethical issues in tuberculosis vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Persistence and boosting of bacille Calmette-Guérin-induced delayed-type hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

The prognosis of latent tuberculosis: can disease be predicted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Synergistic Effect of Bacillus Calmette Guerin and a Tuberculosis Subunit Vaccine in Cationic Liposomes: Increased Immunogenicity and Protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

Planning to improve global health: the next decade of tuberculosis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

T-cell response to mycobacterial proteins: a comparative study of tuberculous and control immunoblots of Mycobacterium tuberculosis and M. bovis BCG

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Effect of vaccines in a murine model of dormant tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Identification of nitric oxide synthase as a protective locus against tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.14

7 January 2021

Identifiers

DOI

10.1038/ICB.2009.14

1 reference

20 August 2017

1 reference

PubMed ID

19350048